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combination is too rare to provide an adequate study group. 
We assume t hat t here is no peculiar antigen distribution in t he 
husbands of these women. We also made no attempt to type 
the children of t hese couples, primarily because of their age. 
Such informat ion would obviously be of great interest. 
Antibodies·against lymphocytes or monocytes occur in most 
women with HG . Most of the women in our study were 1- 5 
years beyond their last pregnancy at the time antibody reactiv-
ity was measured. Since anti-HLA antibodies decrease with 
time, it is likely that an even higher percentage of our patients 
would have had anti -HLA antibodies if studied at the time of 
parturition. 
HLA-A, B, and C antigens are present on essentially all 
nucleated cells, including skin cells (keratinocytes). Only about 
4% of epidermal cells express HLA-DR antigens (Langerhans 
ce lls) . There is no evidence that any of these antigens are 
represented within the BMZ. Further, extensive absorptions of 
Reunala's case with HLA-B8 positive lymphocytes failed to 
alter BMZ staining by t he patient's serum. Thus, anti -HLA 
antibodies are unlikely to play a direct role in the fixation of C 
at the dermal-epidermal junction in patients with HG. 
It is possible that anti-HLA antibodies exert their effect on 
the development of HG indirectly by influencing some aspect 
of immune regulation. It is also possible that the production of 
anti-HLA antibodies, although more common in patients with 
HG , has no relationship to the pathogenesis of this disease. 
The production of these antibodies may be stimulated by the 
same factors that induce anti-BMZ antibody production. Fur-
t her research into the factors that influence product ion of anti-
BMZ and anti-HLA antibodies in this group of patients may 
provide insight into the fundamenta l abnormality of HG. 
The authors wish to thank Gabriel Nunez, M.D. for his help and 
expertise. 
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Kathon Biocide: Manifestation of Delayed Contact Dermatitis in Guinea 
Pigs Is Dependent on the Concentration for Induction and Challenge 
PING KWONG C HAN, PH.D., ROBERT C . BALDWIN, PH.D., RICHARD D. PARSONS, B.S., JACK N. Moss, B.S., 
RoBERT STIRATELLI, Sc.D. , JERRY M. SMITH , PH.D., AND A. WALLACE HAYES, PH.D. 
Toxicology Department, Rohm and Haas Company, Spring Hou.~e. Pennsylvania, U.S.A. 
The potential of Kathon biocide, an aqueous solution 
containing, as active ingredients (a.i.), a mixture of 5-
chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-
isothiazolin-3-one (14.4% a.i.), to produce delayed con-
tact dermatitis, a sensitization response, was evaluated 
in outbred Hartley guinea pigs by a modified Buehler's 
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Abbrev iations: 
a.i. : active ingredients 
EC50: concentration at wh ich delayed contact dermatitis was seen 
in 50% of the population 
occluded epicutaneous patch technique. The relationship 
of the response as a function of induction/elicitation 
concentrations was investigated. Groups of guinea pigs 
received 9 induction doses of the biocide, 3 times a week, 
at concentrations ranging from 25- 2000 ppm a.i. These 
guinea pigs were challenged with the biocide at concen-
trations ranging from 20-2000 ppm a .i. , and the appli-
cation sites were scored for erythema 24 and 48 h after 
the challenge. The incidence of delayed contact derma-
titis in induced guinea pigs was dependent on both the 
induction and challenge concentrations. The EC5 0 (con-
centration at which delayed contact dermatitis was seen 
in 50% of the population) for induction at a challenge 
concentration of 2000 ppm a.i., a nonirritating concen-
tration, was estimated to be 88 ppm a.i. with a slope of 
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3.47 probitsjunit log concentration. The EC50 for elici-
tation at an induction concentration of 1000 ppm a.i. 
was estimated to be 429 ppm a.i. with a slope of 2.74 
probits/unit log concentration. These data demonstrate 
that for Kathon biocide, there is an induction/elicitation 
concentration dependency for delayed contact dermati-
tis response, and there is a "no response concentration" 
zone where the biocide can be used without concern for 
clinically significant delayed contact dermatitis. In com-
parison with a previous study, these data also suggest 
that the number of induction doses may be an important 
factor in demonstrating the sensitization potential of a 
chemical. 
Kathon biocide,* a widely used, broad-spectrum antimicro-
bial agent, contains, as active ingredients (a.i.), a mixture of 5-
chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothia-
zolin -3-one in an approximate ratio of 3:1, respectively, with 
MgCl2 (9%) and Mg(N0 3h (16%) present as stabilizers. The 
biocide is an effective preservative for toi letries, cosmetics, and 
household cleaning products. It is also used in some heavy 
industrial applications such as cooling-tower water, metal-
working fluid, and latex emulsions. 
A variety of industrial chemicals, cosmetic fragrances, and 
therapeutic agents, as well as several naturally occurring sub-
stances such as poison ivy, can cause delayed contact dermatitis 
in animals and humans [1- 3]. These sensitizers fa ll into diver-
sified chemical categories ranging from simple inorganic metals 
such as nickel to complex organic chemicals. Determination of 
the potential for a chemical to cause delayed contact dermatitis 
is often needed for the development of a risk assessment process 
to protect workers and consumers. Since cutaneous contact 
with products containing Kathon biocide is a primary route of 
exposure, the capacity of Kathon biocide to produce delayed 
contact dermatitis was investigated in guinea pigs. 
Beuthet reported that no incidence of delayed contact der-
matitis was observed in guinea pigs even at induction and 
elicitation concentrations as high as 1500 ppm a.i. when the 
biocide was applied once a week for 3 weeks. Parsons:j: reported 
that one of the active ingredients of Kathon biocide, 2-methyl-
4-isothiazolin-3-one, induced delayed contact dermatitis at 
16,000 ppm a.i ., but no response was noted when these induced 
guinea pigs were challenged at 1600 ppm a.i. A concentration-
dependent delayed contact dermatitis response to the biocide 
was also reported in humans [4]. Therefore, another objective 
of this study was to characterize the induction/elicitation con-
centration response relationship for Kathon biocide in guinea 
pigs. 
MATERIALS AND METHODS 
Test Substance and Animals 
An aqueous solution of Kathon biocide (commerc ia l sample) con-
ta ining 14.4% a.i. was used for prepa ring va rious aqueous dilutions. All 
fin al concentrations were confirmed by high -pressure liquid chroma-
tography analysis. 
Outbred Hartley guinea pigs weighing 200-300 g (Charles River 
Breeding Laboratories, Kingston , New York) were individually housed 
in cages with wire bottoms in an airconditioned room with controls set 
to mainta in 20- 22 · c , 45-55 % relative humidity, and a 12-h light cycle. 
Standard laboratory guinea pig chow (Ralston Purina Co., Richmond, 
* Kathon is a Rohm and Haas Company registered tradema rk . The 
active ingredients descr ibed in this report are commercially available 
from Rohm and Haas Co. under the names Kathon 886 MW, Kathon 
WT, Kathan LX, and Kathan CG. 
t Beuthe HF (1982). Expert opi nion concerning the experimental 
sensitivity test of Kathan CG for contact allergy in guinea pigs. Univ-
ersitiit Hamburg, Un iversitiits-Krankenhaus (University Hospita l). 
Private communication. 
:j: Parson RD (1979) . Private communication . 
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Indiana) and water were ava ilable ad libitum except during exposure 
(induction or cha llenge dosing). The a nimals were qua rant ined for at 
least 7 days prior to the study. 
Primary Irritation 
A range-findin g irri tation test was conducted with 4 naive gu inea 
pigs to determine the highest nonirri tating concentration of Kathan 
biocide. Four conce ntrations were applied in a patch to the closely 
clipped backs of t he guinea pigs. The method of app lication and t he 
erythema scoring system were t he same as described in the assessment 
of delayed contact dermatitis. 
Assessment of Delayed Contact Dermatitis 
A modified technique described by Ritz and Bueh ler [5] was em-
ployed to assess delayed contact dermatitis. Nine induction doses, each 
consisting of 0.4 ml of the appropriate aqueous dilution of Katha n 
biocide, were applied under cover to the clipped bac ks of guinea pigs 
for 3 6-h periods per week for 3 consecutive weeks. The patch was 
occluded with a rubber "dental da m," and anima ls were placed in a 
restrainer dur ing eac h of t he exposures. The application s ite was 
washed wi t h wate r a fter the exposure. The treated guinea pigs were 
challenged with 0.4 ml of Kathon biocide by means of a n occluded 
patch, 12- 15 days afte r t he last induction dose. The cha llenge concen-
t rations ra nged from 20- 2000 ppm a.i . Noninduced naive guinea pigs 
were ·aJso challenged with Kathon biocide in the same ma nner a nd at 
t he same concentrations for comparison to erythema due to primary 
irri tation. 
Approximately 24 h after t he challenge exposure, t he backs of the 
guinea pigs were depi lated with Neet lotion hair remover. Two to five 
hours after depilation, t he guinea pigs were scored for erythema reac-
t ions according to the system listed in T able I. Erythema reactions of 
grade 1 or greater were considered positive responses, indicative of 
sensitization in anima ls that received the induction dose. 
EC50 (concentration at which delayed contact dermatit is was seen in 
50% of t he population) values for induction or elicitation of delayed 
contact dermatitis were estimated by probit analys is as described by 
F inney [6]. 
RESULTS 
The highest nonirritating concentration for Kathon biocide 
was 2000 ppm a.i. All concentrations used in the induction or 
challenge phase of the study were equal to or less than 2000 
ppm a.i. 
The incidences of delayed contact dermatitis are listed in 
Table II. No erythema was observed in the noninduced naive 
control guinea pigs. The incidence of delayed contact dermatitis 
was related to the induction concentration; 20/20, 10/ 10, 9/15, 
2/15, and 1/20 guinea pigs induced with 2000, 1000, 500, 100, 
50, and 25 ppm a. i. , respectively, responded to a challenge 
concentration of 2000 ppm a.i. Kathon biocide. Th_e incidence 
of delayed contact dermatitis was also dependent on the elici-
tation concentration. At an induction concentration of 1000 
ppm a.i., 4/5, 3/5, 3/15, and 0/20 guinea pigs responded when 
challenged with 1000, 500, 200, and 50 ppm a.i., respectively. A 
"no response concentration" . zone which is encompassed by 
induction and elicitation concentrations of 2000 and 20 ppm, 
1000 and 50 ppm, 500 and 100 ppm, 50 and 100 ppm, and 25 
arid 200 ppm is suggested by the data in Table II. These 
concentrations are above the recommended final use concen-
tration range of Kathon biocide. The induction/elicitation con-
centration dependency of delayed contact dermatitis response 
is illustrated in a 3-dimensional graph (Fig 1) resulting from 
fitting the sensitization response vs induction or elicitation 
TABLE l. Erythema. scoring system 
Erythema reactions 
No reaction 
Slight patchy erythema 
Sl ight confluent or moderate patchy ery-
thema 
Moderate erythema 
Severe erythema (with or without edema) 
Assigned score 
0 
0.5 
1 
2 
3 
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TABLE II. Incidence of delayed contact dermatitis in gw:nea pigs induced and challenged by various concentrations of Kathan biocides 
Induction" con-
Induction treatment centration (ppm 
a.i.) 2000 1000 
Noninduced cotitrol 0 0/20 
Kathon biocide 2000 20/20 2/2 
1000 4/5 
500 10/ 10 
100 9/15 
50 2/15 
25 1/20 
500 
0/10 
1/2 
3/5 
3/10 
Incidences of delayed contact dermatitis• 
Elicitation Concentration (ppm, a.i.)" 
250 
1/2 
200 
0/ 10 
2/10 
3/15 
1/15 
0/20 
100 
0/10 
1/ 15 
0/15 
0/20 
50 
0/30 
0/20 
0/ 15 
25 
0/ 10 
0/ 20 
20 
0/ 10 
"Dosage volume = 0.4 ml/patch. 
b The number of animals that responded at either 24 or 48 h after the elicitation exposure over the total number of animals challenged in that 
group. 
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FtG 1. A 3-dimensional illustration of the concentration depend-
ency of the delayed contact dermatitis manifested in guinea pigs 
induced and challenged with Kathon biocides. 
concentrations to a logistic model: Log ( p/1-p) = A + Bt 
(induction concentration) + B2 (elicitation concentration) + B:J 
(induction concentration) (elicitation concentration), where P 
= probability of response, and. A = -4.069618, B, = 0.000128, 
B2 = 0.000919, and B:J = 0.000007. 
The calculated EC50 for induction in guinea pigs challenged 
with 2000 ppm a.i. of Kathan biocide was 88 ppm a.i. with 95% 
confidence limits of 66-145 ppm a.i. and a slope of 3.4 7 probits/ 
unit log concentration. The calculated ECr,o for elicitation in 
guinea pigs induced with 1000 ppm a.i. of Kathan biocide was 
429 ppm a.i. with 95 % confidence limits of 272-995 ppm a.i . 
and a slope of 2. 75 probits/unit log concentration. 
DISCUSSION 
The dose-response relationship for a particular toxic re-
sponse is useful information in assessing the risk of a chemical. 
Therefore, it is important to conduct sensitization studies with 
several concentrations of the test substance to evaluate this 
relationship. Sensitization reactions have been considered by 
some as lacking a dose-response relationship [7]; however, 
Marzulli and Maibach [8] have shown a dose-dependent re-
sponse for the induction of delayed contact dermatitis in hu-
mans for several sensitizers including mafenide, benzocaine, 
bronopol, p-phenylenediamine, formalin, and glutaraldehyde. 
They also demonstrated that the delayed contact dermatitis 
response with o-chlorobenzylidine malononitrile and 2-chlo-
roacetophenone was related to the challenge concentration. 
Our data suggest that the potential of Kathan biocide to cause 
delayed contact dermatitis is dependent on both the induction 
concentration and the challenge concentration. These data 
support the conclusion reported by Marzulli and Maibach [8]. 
Although the mechanism of the dependency of delayed contact 
dermatitis on the induction concentration may be different 
from that of the challenge concentration, the clinical signifi-
cance is the same, i.e ., the manifestation of a sensitization 
reaction. Therefore, both concentrations should be taken into 
consideration in any risk assessment. 
Beuthet reported that no incidence of delayed contact der-
matitis was observed in Kathon biocide-treated guinea pigs 
even at induction and challenge concentrations as high as 1500 
ppm a.i. when only 3 induction doses (1 dose per week for 3 
weeks) were employed. In our study, however, 9 induction doses 
at lower concentrations (e.g., 1000 ppm a.i. , 3 doses per week 
for 3 weeks) resulted in sensitization in guinea pigs. These data 
demonstrate that by topical application in guinea pigs, t he 
number of induction doses may be an important factor in 
demonstrating the sensitization characteristic of a chemical. 
On the basis of these results, there is an induction/elicitation 
concentration dependency for delayed contact dermatitis re-
sponse for Kathan biocide, and there is a "no response concen-
t ration" zone where the biocide can be used without concern 
for clinically significant delayed contact dermatitis. 
The authors thank Ms. M. E. De Crescente for her excellent technical 
assistance and Ms. Karen Hendler for typing the manuscript. 
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